NCT00195130

Brief Summary

The primary objective of this prospective study is to develop a new method of classifying the prognosis of ambulatory patients according to their risk of long term mortality, institutionalization, morbidity (including the deterioration of pre-existing conditions or development of new problems) and functional deterioration.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 1998

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 1998

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 1999

Completed
6.7 years until next milestone

First Submitted

Initial submission to the registry

September 15, 2005

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 19, 2005

Completed
Last Updated

March 28, 2008

Status Verified

March 1, 2008

First QC Date

September 15, 2005

Last Update Submit

March 27, 2008

Conditions

Keywords

prognosisrisk of deathmorbiditymortalityquality of life

Outcome Measures

Primary Outcomes (1)

  • To develop a new method of classifying the prognosis of ambulatory patients according to their risk of long term mortality, institutionalization, morbidity and functional deterioration.

Interventions

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \. Patients who are currently under the care of Physicians at Cornell Internal Medicine Associates.

You may not qualify if:

  • Patients who do not wish to participate in the study.
  • Patients who are not able to provide informed written consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

New York Presbyterian Hospital-Weill Cornell Medical College

New York, New York, 10065, United States

Location

Study Officials

  • Mary E Charlson, MD

    Weill Medical College at Cornell University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Sponsor Type
OTHER

Study Record Dates

First Submitted

September 15, 2005

First Posted

September 19, 2005

Study Start

January 1, 1998

Study Completion

January 1, 1999

Last Updated

March 28, 2008

Record last verified: 2008-03

Locations